lipoxin a4 has been researched along with Alzheimer Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assunção, N; Bozza, FA; Canetti, CA; Castro-Faria-Neto, HC; Chauvet, MG; Coutinho, G; Drummond, C; Ferreira, ST; Isaac, AR; Karmirian, K; Ledur, PF; Leo, LM; Lourenco, MV; Mattos, P; Moraes, CA; Ornelas, IM; Pamplona, FA; Paulsen, B; Rehen, SK; Ribeiro, FC; Sudo, FK; Tovar-Moll, F; Vanderborght, B; Vitória, G | 1 |
| Assunção, N; De Felice, FG; Drummond, C; Ferreira, DDP; Ferreira, ST; Gonçalves, RA; Lourenco, MV; Mattos, P; Pamplona, FA; Ribeiro, FC; Sudo, FK; Tovar-Moll, F; Vanderborght, B | 1 |
| Caramelli, P; Carvalho, MDG; de Sousa, LP; de Souza, LC; Ferreira, CN; Fraga, VG; Gomes, KB; Guimarães, HC; Loures, CMG; Magalhães, CA; Zauli, DAG | 1 |
| Dias, IHK; Griffiths, HR | 1 |
| Aytan, N; Benincasa, C; Carreras, I; Crabtree, L; Dedeoglu, A; Jenkins, BG; Kantarci, A; Palaska, I; Stephens, D | 1 |
| Bae, JS; Baek, B; Choi, MK; Han, SH; He, X; Jin, HK; Kim, SH; Lee, JY; Park, MH; Ryu, H; Schuchman, EH; Song, IS; Takuwa, Y | 1 |
| Baglietto-Vargas, D; Cheng, D; Cribbs, DH; Kitazawa, M; LaFerla, FM; Medeiros, R; Passos, GF | 1 |
| Cortés-Toro, V; Eriksdotter, M; Eyjolfsdottir, H; Fitzgerald, JM; Graff, C; Granholm, AC; Hjorth, E; Nennesmo, I; Palmblad, J; Sambamurti, K; Schultzberg, M; Serhan, CN; Wang, X; Zhu, M | 1 |
| Ager, RR; Baglietto-Vargas, D; Cheng, D; Cribbs, DH; Dunn, HC; Kitazawa, M; Medeiros, R | 1 |
| Min, Z; Wang, A; Wu, J; Xiong, Y; Xu, J; Yan, Q; Zhang, J; Zhang, S | 1 |
10 other study(ies) available for lipoxin a4 and Alzheimer Disease
| Article | Year |
|---|---|
Age-linked suppression of lipoxin A4 associates with cognitive deficits in mice and humans.
Topics: Aged; Alzheimer Disease; Animals; Arachidonate 5-Lipoxygenase; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunction; Cytokines; Endocannabinoids; Humans; Inflammation; Inflammation Mediators; Lipoxins; Mice | 2022 |
Cerebrospinal fluid irisin and lipoxin A4 are reduced in elderly Brazilian individuals with depression: Insight into shared mechanisms between depression and dementia.
Topics: Alzheimer Disease; Animals; Brain-Derived Neurotrophic Factor; Brazil; Depression; Fibronectins; Lipoxins | 2023 |
Inflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Annexin A1; Cytokines; Diagnosis, Differential; Female; Frontotemporal Dementia; Genotype; Healthy Volunteers; Humans; Inflammation; Lipoxins; Male; Middle Aged | 2019 |
Current and Future Directions for Targeting Lipoxin A4 in Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Brain; Humans; Inflammation; Inflammation Mediators; Lipoxins | 2021 |
Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Hippocampus; Inflammation; Lipoxins; Mice; Mice, Transgenic | 2018 |
Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease.
Topics: Acetyl Coenzyme A; Adaptor Proteins, Signal Transducing; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cyclooxygenase 2; Disease Models, Animal; Humans; Lipoxins; Male; Mice; Mice, Transgenic; Microglia; Neurons; Phagocytosis; Presenilin-1; Serine; Transgenes | 2018 |
Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aspirin; Astrocytes; Brain; Cognition; Lipoxins; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; NF-kappa B; Phenotype; Protein Processing, Post-Translational; Synapses | 2013 |
Resolution of inflammation is altered in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Docosahexaenoic Acids; Female; Hippocampus; Humans; Inflammation; Inflammation Mediators; Lipoxins; Lipoxygenase; Male; Middle Aged; Receptors, Formyl Peptide; Receptors, Lipoxin; tau Proteins | 2015 |
Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model.
Topics: Alzheimer Disease; Animals; Brain; Cognition; Disease Models, Animal; Disease Progression; Lipoxins; Mice; Mice, Transgenic; Microglia; Phosphorylation; Recognition, Psychology; Signal Transduction | 2015 |
Lipoxin A4 inhibits the production of proinflammatory cytokines induced by β-amyloid in vitro and in vivo.
Topics: Active Transport, Cell Nucleus; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line; Cell Nucleus; Cerebral Cortex; Cytokines; Hippocampus; I-kappa B Proteins; Inflammation; Interleukin-1beta; Lipoxins; Male; Mice; Mice, Inbred C57BL; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2011 |